Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA067174-01A1
Application #
2110780
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1996-03-01
Project End
1999-12-31
Budget Start
1996-03-01
Budget End
1996-12-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Microbiology/Immun/Virology
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Santamaria, A B; Davis, D W; Nghiem, D X et al. (2002) p53 and Fas ligand are required for psoralen and UVA-induced apoptosis in mouse epidermal cells. Cell Death Differ 9:549-60
Stern, Robert S; Bolshakov, Svetlana; Nataraj, Arun J et al. (2002) p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: evidence for heterogeneity and field cancerization. J Invest Dermatol 119:522-6
Kutach, L S; Bolshakov, S; Ananthaswamy, H N (1999) Detection of mutations and polymorphisms in the p53 tumor suppressor gene by single-strand conformation polymorphism analysis. Electrophoresis 20:1204-10
Nataraj, A J; Wolf, P; Cerroni, L et al. (1997) p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA). J Invest Dermatol 109:238-43
Nataraj, A J; Black, H S; Ananthaswamy, H N (1996) Signature p53 mutation at DNA cross-linking sites in 8-methoxypsoralen and ultraviolet A (PUVA)-induced murine skin cancers. Proc Natl Acad Sci U S A 93:7961-5